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CONTROLLED METHOD OF R E D U C I N G  E L E C T R O P H O R E T I C  
M O B I L I T Y  OF V A R I O U S  SUBSTANCES 
The p r e s e n t  i n v e n t i o n  i s  d i r e c t e d  t o  a me thod  f o r  
q u a n t i t a t i v e l y  r e d u c i n g  e l e c t r o p h o r e t i c  m o b i l i t y  o f  
m a c r o m o l e c u l e s ,  p a r t i c l e s ,  a n d  c e l l s  i n  a c o n t r o l l e d ,  
c o n c e n t r a t i o n - d e p e n d e n t  manner  by  i n t e r a c t i n g  t h e  
s u b s t a n c e s  w i t h  n e u t r a l ,  p o l y m e r - l i n k e d  a f f i n i t y  
compounds .  The  method w i l l  b e  u s e f u l  i n  a c h i e v i n g  
e l e c t r o p h o r e t i c  s e p a r a t i o n  f o r  a l a rge  number of s u b s t a n c e s  
o r  p a r t i c l e s  whose n o r m a l  e l e c t r o k i n e t i c  c h a r g e  s t r u c t u r e  
would  n o t  a l l o w  s e p a r a t i o n  u n d e r  p a s t  s y s t e m s .  I t  h a s  
p o t e n t i a l  f o r  b o t h  p r e p a r a t i v e  a n d  a n a l y t i c a l  u s e .  
The method o f  t h e  i n v e n t i o n  c o m p r i s e s  i n t e r a c t i n g  t h e  
s u b s t a n c e s  o f  i n t e r e s t  w i t h  a two-component  s y s t e m  
c o n s i s t i n g  p r i m a r i l y  of a h y d r o p h i l i c  n e u t r a l  p o l y m e r  a n d  a 
s e c o n d  a f f i n i t y  componen t  c o n s i s t i n g  o f  a h y d r o p h o b i c  
compound,  a n d  immunocompound, o r  a l i g a n d .  I t  i s  prefer red  
t h a t  t h e  h y d r o p h i l i c  n e u t r a l  p o l y m e r  u s e d  i n  t h e  i n v e n t i o n  
c o m p r i c s e  p o l y e t h y l e n e  g l y c o l  (PEG) ,  h o w e v e r ,  o t h e r  
s u i t a b l e  p o l y m e r s  s u c h  as  p o l y v i n y l  a l c o h o l ,  p o l y v i n y l  
p y r r o l i d o n e  o r  p o l y p r o p y l e n e  g l y c o l  may a l s o  b e  e m p l o y e d .  
The h y d r o p h o b i c  compound u s e d  i n  t h e  two-component  s y s t e m  
i s  p r e f e r a b l y  a f a t t y  a c i d  a l k y l  d e r i v a t i v e ,  o r  a c y l  g r o u p ,  
e . g . ,  a h e x a d e c a n e  o r  o c t a d e c a n e  t a i l .  T h e  immunocompound 
i n  t h e  s y s t e m  c a n  i n c l u d e  a n t i b o d i e s  o r  a c t i v e  f r a g m e n t s  
d e r i v e d  the re f rom,  e . g . ,  F ( a b )  o r  F c ,  o r  s imilar  
m a c r o m o l e c u l e s  w i t h  b i n d i n g  s p e c i f i c i t y ,  e . g . ,  P r o t e i n  A ,  
P r o t e i n  G ,  A v i d i n ,  o r  C o n c a n a v a l i n  A .  The  l i g a n d s  u s e f u l  
i n  t h e  i n v e n t i o n  i n c l u d e  h o r m o n e s ,  a n t i g e n s ,  enzyme 
i n h i b i t o r s ,  a n d  h a p t e n s .  E l e c t r o p h o r e t i c  s e p a r a t i o n  c a n  b e  
a c c o m p l i s h e d  i n  a v a r i e t y  o f  d i f f e r e n t  m a n n e r s  ( i . e . ,  
s p e c i f i c / r e v e r s i b l e ,  s p e c i f i c / i r r e v e r s i b l e ,  
n o n - s p e c i f i c / r e v e r s i b l e ,  e t c . )  d e p e n d i n g  o n  t h e  p a r t i c u l a r  
two-component  s y s t e m  s e l e c t e d  t o  i n t e r a c t  w i t h  t h e  d e s i r e d  
m a c r o m o l e c u l e s ,  p a r t i c l e s ,  o r  c e l l s .  
The n o v e l t y  of t h e  i n v e n t i o n  a p p e a r s  t o  l i e  i n  t h e  u s e  of 
t h e  two-component  s y s t e m  t o  a c h i e v e  s e p a r a t i o n  i n  a v a r i e t y  
o f  m a c r o m o l e c u l e s ,  c e l l s ,  e t c .  i n  a c o n t r o l l e d ,  
c o n c e n t r a t i o n - d e p e n d e n t  m a n n e r  u n o b t a i n a b l e  i n  t h e  p r i o r  
a r t .  T h e  m o b i l i t y  of t h e  t r e a t e d  s u b s t a n c e  i s  r e d u c e d  i n  a 
c o n c e n t r a t i o n - d e p e n d e n t  m a n n e r  by m a s k i n g  t h e  l l e f f e c t i v e l l  
o r  l l a p p a r e n t l l  s u r f a c e  c h a r g e  u s i n g  t h e  n e u t r a l  p o l y m e r .  
The r e d u c t i o n  i n  e l e c t o p h o r e t i c  m o b i l i t y  w i l l  b e  d i r e c t l y  
p r o p o r t i o n a l  t o  t h e  amount  o f  t h e  two-component  a f f i n i t y  
compound employed  i n  t h e  a s s a y .  T h e  t e c h n i q u e  c a n  b e  
employed  u s i n g  s t a n d a r d  l a b o r a t o r y  e l e c t o p h e r e s i s  
e q u i p m e n t .  
I n v e n t o r :  
E m p l o y e r :  
Date F i l e d :  
James M .  Van A l s t i n e  
U S R A  
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~ - -  CONTROLLED METHOD OF REDUCING ELECTROPXORETIC 
MOBILITY OF PARTICLES, CELLS, AND THE LIKE 
ORIGIN OF THE INVENTION 
The invention described herein was made in the 
5 performance of work under a NASA contract and is 
subject to the provisions of Section 305 of the 
National Aeronautics and Space Act of 1958, Public Law 
85-568 (72 Stat. 435; 43 U . S . C .  2457). 
FIELD OF THE INVENTION 
10 The invention relates in general to a rethod for 
quantitatively reducing electrophoretic mobility of 
particles, cells and macromolecules, and specifically 
to a method of reducing electrophoretic mobility in ? 
concentration-dependent manner by interacting 
i 5  substances with neutral polymer-linked affinity 
compounds. 
BACKGROUND OF THE INVENTION 
For years, electrophoresis has been used to 
separate and isolate macromolecules and particles, due 
\' to differences in apparent surface charge. When two 7 
substances have the same charge but - different 
mobilities, the faster moving substances will overrun 
and migrate ahead of the slower one. This is usually 
due to substance geometry and other hydrodynamic 
25 considerations. In general, the affinity of one 
&I i'L 2 0  
%-@t 
substance to another will affect the mobility of th-at 
substance when both are subjected to electrophoresis. 
It is thus theoretically possible to maximize 
separation of particles with the same or similar 
30 charges through the use of specific affinity 
compounds. For a general review of affinity 
electrophoresis (of macromolecules) , see Takeo, 
Electrophoresis 5: 187-195 (1984) . 9 J4 
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A f f i n i t y  e l e c t r o p h o r e s i s  t e c h n i q u e s  a re  of 
e n o r m o u s  p o t e n t i a l  v a l u e  i n  a v a r i e t y  o f  m e d i c a l  
b i o c h e m i c a l  a r eas  ( e . g . ,  r e s e a r c h ,  d i a g n o s t i c s ) .  O f  
p a r t i c u l a r  i m p o r t a n c e  w i l l  b e  t e c h n i q u e s  f o r  i s o l a t i n g  
o r  s e p a r a t i n g  v e r y  l a r g e  m o l e c u l e s  o r  c e l l s  s u c h  as  
c a n c e r  c e l l s ,  b l o o d  c e l l s ,  D N A  m o l e c u l e s ,  l y m p h o c y t e s ,  
p r o t e i n s ,  e t c .  N e w  t e c h n i q u e s  a r e  n e e d e d  s i n c e ,  i n  a 
g rea t  number o f  cases ,  t h e  c e l l s  o r  p a r t i c l e s  of 
i n t e r e s t  a re  n o t  a m e n a b l e  t o  p r e s e n t l y  known 
e l e c t r o p h o r e t i c  s e p a r a t i o n  t e c h n i q u e s .  T h i s  i s  
p a r t i c u l a r l y  t r u e  f o r  c e l l s  w h i c h  a r e  e a s i l y  damaged 
by t h e  e x t r e m e  c o n d i t i o n s  ( t e m p ,  pH, s a l t  
c o n c e n t r a t i o n ,  f l u i d  shea r )  o f  many ( e l e c t r o p h o r e t i c )  
s e p a r a t i o n  t e c h n i q u e s .  U n f o r t u n a t e l y ,  i t  i s  a l s o  t r u e  
t h a t  m o s t  c e l l s  h a v e  r e a s o n a b l y  s imilar  
e l e c t r o p h o r e t i c  m o b i l i t i e s  ( a p p r o x i m a t e l y  0 .9  2 0 . 3  
JA -1 -1 d m s  v cm). 
E l e c t r o p h o r e t i c  s e p a r a t i o n  m e t h o d s  f o r  s u c h  s u b s t a n c e s  7 - y e  
n e e d  t o  b e  s p e c i f i c  as r e g a r d s  t h e i r  p h y s i o l o g i c a l  
s i g n i f i c a n c e .  I t  i s  e x t r e m e l y  i m p o r t a n t  t h a t  t h e  
r a n g e  o f  e l e c t r o p h o r e t i c  m o b i l i t y  b e  c o n t r o l l e d ,  
p r e f e r a b l y  i n  a c o n c e n t r a t i o n - d e p e n d e n t  m a n n e r .  
- 
The  u s e  o f  a f f i n i t y  a g e n t s  s u c h  a s  a n t i b o d i e s  t o  
e n h a n c e  t h e  s p e c i f i c i t y  of e l e c t r o p h o r e s i s ,  a n d  
d e v e l o p  a u s e f u l  s y s t e m  by  w h i c h  a l a r g e  number  of 
p a r t i c l e s  a n d  c e l l s  c o u l d  b e  s e p a r a t e d  was t h e o r i z e d  
as  e a r l y  as t h e  1920's.  However ,  a n t i b o d y - i n d u c e d  
c e l l  a g g r e g a t i o n ,  a n d  a d e m o n s t r a t e d  l a c k  o f  c e l l -  
a n t i b o d y  i n t e r a c t i o n  a p p r e c i a b l y  a l t e r i n g  s u b s t a n c e  
e l e c t r o p h o r e t i c  m o b i l i t y  k e p t  t h e  g o a l  a t  arms 
l e n g t h .  P r e v i o u s  research i n  t h i s  f i e l d  a t t e m p t e d  t o  
u s e  immuno-compounds a n d  o t h e r  a g e n t s  t o  a f f e c t  
- 3 -  
5 
electrophoretic mobility of various cells. 
example, Seaman, pgs. 1135-1229 in The Red Blood Cell, 
Vol. 3 (1975), discloses modifying red blood cell 
surfaces with such materials as antisera, enzymes, and 
neutral polymers. In the first two cases (antisera 
and enzymes), problems were reported including 
aggregation, limited reductions of mobility of the 
cells, and a general lack of specifity in the 
treatments. It was found that the use of neutral 
polymers actually increased particle electrophoretic 
mobility. 
blood cells (mentioned above) has also been reported 
by Sachtleben, in Cell Electrophoresis, pgs. 100-114 
(1965). 
up to about a 4 0 %  reduction in electrophoretic 
mobility in epithelial cells and lymphocytes was 
reported in Cohly et a1 in Cell Electrophoresis, pgs. 
611-616 (1985). (In an attempt to alter net cell 
surface charge, rather than cell surface 
20 electrohydrodynamics, these authors exposed cells 
covered with antibodies to secondary anti-antibodies 
whose net positive charge, they hoped, would partially 
neutralize the cells native net negative charge.) 
For 
10 
Effects of unmodified antibodies on red 
The use of a double antibody system yielding 
15 
- 
Thus previous attempts in reducing mobility generally 
25 suffered from aggregation, and large, controlled 
reductions in electrophoretic mobility have not been 
achieved. 
In the patent art, many attempts at separating 
biological cells and other compounds through 
30 electrophoresis are known. For instance, U.S. Patent 
No. 4,474,886 (Willard) relates to the use of SDS 
polyacrylamide gel in gel electrophoresis wherein the 
SDS gel binds to proteins to aid in separation by 
mass. The SDS is charged and uniformly coats the 
. 
- 4  - 
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10 
15  
macromolecule creating uniform charge per unit area. 
Thus separation is on the basis of surface area which 
is related to size. SDS kills cells, which regardless 
cannot be subjected to such gel electrophoresis. 
Independent of these blocks, this method would not aid 
in separating two molecular samples of similar mass 
which have different charges. 
A s  indicated above, the use of neutral polymers in 
affecting electrophoretic mobility has been examined. 
It has been observed that such polymers typically 
cause an increase, and not a decrease, in the 
electrophoretic mobility (see Brooks, J. Colloid 
Interf. Sci., 1971 and Seaman, above). Various 
researchers have employed charged polymers in methods 
to obtain decreases in the mobility of macromolecules 
but not particles. 
described in references such as Shimura et al., 
Electrophoresis 8:135-139 (1987) (charged polylysine 
added to ligand to aid biomolecule separation), and 
(electrophoretic separation achieved through use of 
charged polyethylene glycol ions). These techniques 
do not aid in l1rnaskingtg the native surface charge of 
macromolecules, particles or cells, because the 
will neutralize, not remove or mask, native charges on 
the macromolecules. What has not been accomplished, 
therefore, is the development of a system by which 
hydrophilic, uncharged polymers, such as polyethylene 
electrophoretic mobility by altering the hydrodynamic 
nature of the llsurfacell of cells, particles and 
macromolecules in a concentration-dependent manner 
and/or in a manner based on their specific antigenic 
Examples of these techniques are 
20 Vestermark, German Patent No. 2,040,091 
- 
25 polymers in these cases are of opposite charge and 
30 glycol (PEG), can be used to substantially reduce 
35 characteristics. 
SUMMARY OF THE INVENTION 
A c c o r d i n g  t o  t h e  p r e s e n t  i n v e n t i o n ,  a me thod  of 
r e d u c i n g  e l e c t r o p h o r e t i c  m o b i l i t y  o f  m a c r o m o l e c u l e s ,  
p a r t i c l e s ,  c e l l s  a n d  t h e  l i k e  i n  a c o n t r o l l e d  manner  
m a c r o m o l e c u l e s ,  p a r t i c l e s  o r  c e l l s  w i t h  a 
p o l y m e r - l i n k e d  a f f i n i t y  compound c o m p r i s e d  o f  a 
h y d r o p h i l i c  n e u t r a l  p o l y m e r ,  s u c h  a s  p o l y e t h y l e n e  
g l y c o l ,  a n d  a componen t  s e l e c t e d  from t h e  g r o u p  
immunocompound, s u c h  as  a n  a n t i b o d y  o r  a c t i v e  a n t i b o d y  
f r a g m e n t  o r  s imilar  m a c r o m o l e c u l e  w i t h  b i n d i n g  
s p e c i f i c i t y  ( e . g . ,  P r o t e i n  A ,  A v i d i n ,  P r o t e i n  G ,  
C o n c a n a v a l i n  A ) ,  a n d  a l i g a n d .  The  r e d u c t i o n  i n  
i n v e n t i o n  i s  u p  t o  a p p r o x i m a t e l y  100% f o r  p a r t i c u l a r  
s u b s t a n c e s ,  a n d  t h e  m o b i l i t y  r e d u c t i o n  a c h i e v e d  i s  
d i r e c t l y  p r o p o r t i o n a l  t o  t h e  c o n c e n t r a t i o n  of t h e  
i n t e r a c t i n g  a f f i n i t y  compound e m p l o y e d .  The  p r e s e n t  
5 i s  p r o v i d e d  w h i c h  c o m p r i s e s  i n t e r a c t i n g  t h e  
10 c o n s i s t i n g  o f  a h y d r o p h o b i c  compound,  a n  
i 5  e l e c t r o p h o r e t i c  m o b i l i t y  a c h i e v a b l e  i n  t h e  p r e s e n t  
20 i n v e n t i o n  i s  a d v a n t a g e o u s  i n  t h a t  e l e c t r o p h o r e t i c  
s e p a r a t i o n  i s  now p o s s i b l e  f o r  s u b s t a n c e s  o r  p a r t i c l e s  
whose n o r m a l  e l e c t r o k i n e t i c  c h a r g e  s t r u c t u r e  wou ld  n o t  
a l l o w  - s e p a r a t i o n .  T h i s  s e p a r a t i o n  c a n  b e  a c h i e v e d  
w i t h  s p e c i f i t y ,  a n d  i n  a c o n t r o l l e d ,  avzahjfika& 
i n t e r a c t i o n  of t h e  a f f i n i t y  compound w i t h  t h e  
s u b s t a n c e . o f  i n t e r e s t  c a n  b e  t a i l o r e d  i n  t h e  r a n g e  of 
r e v e r s i b l e  t o  i r r e v e r s i b l e .  
25 c o n c e n t r a t i o n - d e p e n d e n t  m a n n e r .  F u r t h e r m o r e ,  t h e  
30 BRIEF DESCRIPTION .OF THE D R A W I N G  FIGURES 
F i g u r e  1 i s  a g r a p h i c  r e p r e s e n t a t i o n  o f  t h e  
e f f e c t s  o f  i m m u n o - a f f i n i t y  compounds  of t h e  p r e s e n t  
i n v e n t i o n  i n  r e d u c i n g  e l e c t r o p h o r e t i c  m o b i l i t y  of 
c e l l s .  
35 F i g u r e  2 i s  a g r a p h i c  r e p r e s e n t a t i o n  of t h e  
e f f e c t s  o f  h y d r o p h o b i c  a f f i n i t y  compounds  o f  t h e  
p r e s e n t  i n v e n t i o n  i n  r e d u c i n g  e l e c t r o p h o r e t i c  m o b i l i t y  
o f  c e l l s .  
DETAILED DESCRIPTION OF ‘1’HE PkEFERRED EMBODIMENTS 
In the present invention, a hydrophilic neutral 
polymer such as polyethylene glycol is used in a 
two-component system to reduce electrophoretic 
5 mobility in a wide variety of macromolecules, 
particles and cells. 
has been known in the separation of cells, such as 
described in Karr et al, J. Chromatoqraphv 354: 
269-282 (1986), in which it is employed in a phase 
The use of polyethylene glycol 
1 0  partitioning system. However, phase partitioning, a 
liquid-liquid extraction technique which is relatively 
three-dimensional and energy independent, is quite 
unrelated to electrophoresis procedures, which are 
energy dependent and involve linear separation of 
15 materials based on differences in apparent surface 
charge. 
Patent, No. 4,690,749 (Van Alstine et al), to employ 
PEG in controlling electroosmosis. However,, in that 
patent, the PEG is permanently (i.e., covalently) 
20 linked to the surface of nonliving particles so as to 
produce test particles, e.g., glass beads, of defined 
mobility. In the present invention, the PEG-linked 
affinity compounds do not permanently bind to the 
particle or cell separated, and the technique 
25 disclosed herein can be used specifically for 
separating desired or target cells, after which the 
affinity ligand is released from and/or metabolized by 
those cells. 
It has also been disclosed in a previous U.S. 
- 
In the embodiments of the present invention, the 
electrophoretic mobility in a controlled manner will 
be comprised primarily of a hydrophilic neutral 
polymer and a second component consisting of a 
hydrophobic compound, an immuno-compound, including 
30 polymer-linked affinity compound employed to reduce 
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active antibody fragments or similar macromolecule or 
with binding specificity (e.g., Protein A, Avidin, 
Protein G, Concanavalin A ) ,  or a ligand. For all of 
the embodiments, it is preferred that the hydrophilic 
neutral polymer neutral polymer employed comprise 
polyethylene glycol (PEG). However, other hydrophilic 
neutral polymers which can be covalently coupled to 
the second component of the polymer-linked affinity 
compound may be employed and may be advantageous under 
certain specific applications. Other neutral 
hydrophilic polymers usable in the invention include 
polyvinyl alcohol, polyvinyl pyrrolidone, 
polypropylene glycol, polyethylene 
glycol-polypropylene glycol co-polymers, and 
polypropylene glycol-polyethylene glycol co-block 
polymers. 
A s  discussed previously, it had been observed that 
adsorption of neutral polymers typically increased the 
electrophoretic mobility of particles and cells. This 
is most likely due to the fact that the particles or 
cells non-specifically adsorb the polymers at multiple 
polymer contact points on their surface (see Brooks, 
above and Seaman, above). In the present invention, 
the hydrophilic neutral polymer-containing compounds 
adsorb at the "surface" of the macromolecule, cell or 
particle via demonstrably specific interactions. A s  a 
result, these adsorbate neutral affinity compounds 
alter particle or molecular electrohydrodynamic 
interaction with the suspending medium (increase local 
viscosity) at the particles or macromolecule's 
ltsurfacel', lowering cell/particle mobility. In the 
case of macromolecules, the affinity compounds of the 
present invention similarly contact the macromolecule 
at its outer periphery and alter its hydration, and 
- 
r 
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the effect in reducing electrophoretic mobility is 
analogous to the effect of the compounds on the outer 
layers of cell or particle surfaces. 
invention, an immunocompound or fragment thereof, is 
employed as the second component of the polymer-linked 
affinity compound. By immunocompound is meant 
antibodies or fragments thereof, or similar compounds 
(such as Concanavalin A, Protein G, Protein A, Avidin) 
which can bind to specific "antigenst1. Particularly 
useful in the present invention are immunoglobulins 
(e.g., IgG) and their active fragments (e.g., F(ab) or 
Fc) derived therefrom. However, any antibody of human 
or animal derivation may be successfully employed in 
the invention. It has been shown by a group of 
authors including Karr, Harris, Van Alstine, et al., 
that PEG derivatized Protein A (which binds to 
antibody molecules)- can be used to effect 
Immunoaffinity Partition. This technique may also 
work for Immunoaffinity electrophoresis using 
PEG-Protein A or PEG-Protein G and unmodified 
antibodies or PEG-Avidin and Biotin-conjugated 
antibodies, etc. Affinity compounds containing an 
immunocompound as a second component are particularly 
advantageous in that they can be made very specific to 
a particular cell, particle, or macromolecule, and can 
be used successfully to reduce mobility in a large 
number of substances having a surface or outer 
periphery charge structure which normally would not 
allow them to be separated by electrophoretic means. 
Immuno-affinity compounds are thus effective in 
reducing electrophoretic mobility of specific 
particles (e.g., cells such as subpopulations of 
lymphocytes) or any other molecules to which the 
antibodies or their active fragments can be directed. 
In one of the preferred embodiments of the 
- 
An a d d i t i o  a 1  f e a t u r e  of  t h i  a zct  of t h e  
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i n v e n t i o n  i s  t h e  o b s e r v a t i o n  t h a t  t h e  a n t i b o d y / n e u t r a l  
p o l y m e r  compounds  g r e a t l y  r e d u c e  t h e  t e n d e n c y  t o  
a g g r e g a t e  c e l l s  o r  p a r t i c l e s ,  w h i c h  wou ld  h i n d e r  
s p e c i f i c  c e l l  s e p a r a t i o n ,  w h i l e  a t  t h e  same t ime 
p r o v i d i n g  c o n c e n t r a t i o n - d e p e n d e n t  r e d u c t i o n  i n  c e l l  o r  
p a r t i c l e  e l e c t r o p h o r e t i c  m o b i l i t y .  
i m m u n o - a f f i n i t y  compounds o f  t h e  p r e s e n t  i n v e n t i o n  a re  
a g r e a t  i m p r o v e m e n t  o v e r  p r e v i o u s  compounds  as  
r e p o r t e d  a b o v e  w h i c h  o n l y  a c h i e v e d  u p  t o  a b o u t  40% 
r e d u c t i o n  i n  e l e c t r o p h o r e t i c  m o b i l i t y .  I n  t h e  p r e s e n t  
i n v e n t i o n ,  r e d u c t i o n  i n  c h a r g e  a n d  t h e  m o b i l i t y  o f  u p  
t o  100% c a n  b e  a c h i e v e d ,  a n d  t h i s  r e d u c t i o n  i s  
o b t a i n e d  i n  a c o n c e n t r a t i o n - d e p e n d e n t  m a n n e r .  I n  many 
cases  t h e  i n t e r a c t i o n  c a n  be  r e v e r s e d  a n d  i n  t h e  case 
o f  l i v i n g  c e l l s  s u r f a c e  l o c a l i z e d  a f f i n i t y  compounds  
may b e  m e t a b o l i z e d  f o l l o w i n g  c e l l  s e p a r a t i o n .  
The anaq-ckbL d&L 
I n  a n o t h e r  embodiment  o f  t h e  p r e s e n t  i n v e n t i o n ,  
t h e  s e c o n d  componen t  i n  t h e  p o l y m e r - l i n k e d  a f f i n i t y  
compound c o m p r i s e s  a h y d r o p h o b i c  compound.  I t  i s  
p a r t i c u l a r l y  p r e f e r r e d  t h a t  t h e  h y d r o p h o b i c  compound 
c o m p r i s e  a f a t t y  ac id  a l k y l  d e r i v a t i v e  o r  a c y l  g r o u p  
w i t h  a h e x a d e c a n e ,  o c t a d e c a n e ,  e t c .  t a i l  i n c l u d i n g  
p a l m i t i c  ac id - ,  s t e a r i c  a c i d ,  o l e i c  a c i d ,  e t c .  
However ,  l i p i d s  a n d  o t h e r  h y d r o p h o b i c  compounds  w h i c h  
c a n  b e  c o v a l e n t l y  l i n k e d  t o  t h e  h y d r o p h i l i c  n e u t r a l  
p o l y m e r ,  s u c h  as 1 - a m i n o - o c t a d e c a n e  may a l s o  b e  
employed .  T h e  h y d r o p h o b i c  compounds c a n  b e  l i n k e d  t o  
t h e  h y d r o p h i l i c  n e u t r a l  p o l y m e r  by  means  of a n  ester 
l i n k a g e  ( s e e  F i g u r e  2 ) ,  b u t  l i n k a g e  t h r o u g h  a n  e t h e r ,  
a m i n e  o r  o t h e r  f u n c t i o n a l  g r o u p  i s  p o s s i b l e .  The  
h y d r o p h o b i c - a f f i n i t y  compounds  of t h e  p r e s e n t  
i n v e n t i o n  show some s p e c i f i t y  as t o  t h e  c e l l s  a n d  
p a r t i c l e s  f o r  w h i c h  m o b i l i t y  i s  t o  b e  r e d u c e d ,  a n d  
t h e s e  compounds  h a v e  b e e n  p r e f e r a b l y  u s e d  i n  t h e  
s e p a r a t i o n  of s p e c i f i c  c e l l s  s u c h  as  cancer c e l l s  o r  
r e d  b l o o d  c e l l s .  A p a r t i c u l a r  a d v a n t a g e  of t h e  
x 
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h y d r o p h o b i c - a f f i n i t y  compounds  i s  t h a t  t h e  b i n d i n g  
w i t h  t h e  c e l l s  t r e a t e d  i s  r e a d i l y  r e v e r s i b l e .  T h i s  
f e a t u r e  i s  h i g h l y  a d v a n t a g e o u s  where i t  i s  d e s i r e d  t o  
s e p a r a t e  c e l l s ,  t h e n  r emove  t h e  a f f i n i t y  compound s o  
5 t h a t  t h e  s e p a r a t e d  c e l l s  c a n  b e  e x a m i n e d .  The  
compounds  a re  n o t  h a r m f u l  t o  e l e c t r o p h o r e t i c  a p p a r a t i i  
a n d  a r e  u s e d  i n  s u c h  low c o n c e n t r a t i o n  t h a t  t h e y  c a n  
be  e a s i l y  a n d  c h e a p l y  a d d e d  t o  t h e  b u f f e r  s o l u t i o n s  
n o r m a l l y  u s e d  i n  e l e c t r o p h o r e t i c  t e c h n i q u e s .  
10 I n  s t i l l  a n o t h e r  a s p e c t  o f  t h e  p r e s e n t  i n v e n t i o n ,  
t h e  s e c o n d  c o m p o n e n t  of t h e  p o l y m e r - l i n k e d  a f f i n i t y  
compound c o m p r i s e s  a l i g a n d .  L i g a n d s  u s e f u l  i n  t h e  
p r e s e n t  i n v e n t i o n  may c o m p r i s e  a w i d e  v a r i e t y  o f  small 
m a c r o m o l e c u l a r  s u b s t r a t e s ,  s u c h  as  hormones  o r  
:5 a n t i g e n s ,  o r  low m o l e c u l a r  w e i g h t  s u b s t a n c e s  s u c h  a s  
enzyme i n h i b i t o r s  a n d  h a p t e n s .  The  p r e s e n t  i n v e n t i o n  
d i f f e r s  from t h e  p r e v i o u s  work  of M u l l e r  e t  a l ,  
N u c l e i c  Acid R e s e a r c h  9:95-115 (19811 ,  i n  w h i c h  d y e s  
were c o v a l e n t l y  bound t o  a p o l y e t h y l e n e  g l y c o l  t o -  
s p e c  i f i c  a 1 1 y i n c  r ea se  t h e  f r i c  t i o  n a l  f t  s u r  f ac err 
t h a t  t h e  M u l l e r  e t  a1 a r t i c l e  d i d  n o t  d i s c l o s e  u s e  of 
t h e  d y e s  i n  b i n d i n g  c e l l s  o r  o t h e r  p a r t i c l e s .  T h e  
l i g a n d - a f f i n i t y  compounds  -of t h e  p r e s e n t  i n v e n t i o n  c a n  
b e  employed  t o  r e d u c e  t h e ' n o n - g e l  b a s e d  
e l e c t r o p h o r e t i c  m o b i l i t y  o f  c e l l s  a n d  p a r t i c l e s  i n  
a d d i t i o n  t o  m a c r o m o l e c u l e s .  A d d i t i o n a l l y ,  t h e  
l i g a n d - a f f i n i t y  compounds  of t h e  p r e s e n t  i n v e n t i o n  
20 
c o e f f i c i e n t  of D N A  m o l e c u l e s  g e l  e l e c t r o p h o r e s i s ,  i n  3 0 4  
7&4R 
-. 
c p  b d  
n 25 
7/%~8Q 
w i l l  be  o f  v a r y i n g  r e v e r s i b i l i t y ,  d e p e n d i n g  upon  t h e  
30 p a r t i c u l a r  l i g a n d  c h o s e n ,  a n d  r e d u c e  t h e  m o b i l i t y  o f  
c e l l s  a n d  p a r t i c l e s  i n  a c o n c e n t r a t i o n - d e p e n d e n t  
m a n n e r .  
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In accordance with the present invention, 
electrophoretic separation can be accomplished in a 
variety of different manners. 
affinity component utilized, separation can be 
achieved on the basis of specific/irreversible (e.g., 
PEG-derivatized antibody), specific/reversible (e.g., 
PEG-derivatized lectin), semi-specific, reversible 
(e.g., PEG-hydrophobic affinity ligand such as 
unsaturated PEG-fatty acid ester), relatively 
ester or PEG-ionic interaction group (trimethylamine 
Depending on the 
10 nonspecific reversible (e.g., saturated PEG-fatty acid 
or sulphate)) or relatively nonspecific-irreversible 
(e.g., PEG-cyanuric chloride) interactions. 
- a.ry;** q f w p  
A @% 
In general, the affinity compounds appear to 
15 operate in reducing mobility of the macromolecules, 
cells, or particles treated by masking the Iteffective 
or apparent" surface charge. The neutral polymers 
apparently increase fluid viscous resistance to 
ttsurfacett flow when anchored via the second component 
of the affinity compound to the particular cell, 
particle, or macromolecule separated. A 'general 
background as to the theory of electrophoresis and the 
effects of increasing local surface resistance to 
fluid flow can be found in Levine et al, Biophys. J. 
20  
- 
25 42:127-135 (1983). In the present invention, the more 
neutral polymers which can be attached to the unit to 
be separated, the greater the effect in reducing 
mobility. Thus the reduction in -electrophoretic 
mobility may be obtained in a manner directly 
employed in the electrophoretic assay. The ability of 
the affinity compounds of the present invention to 
achieve concentration-dependent reduction in 
30 proportional to the amount of affinity compound 
-12- 
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electrophoretic mobility has been confirmed in 
experimental tests. Their ability to specifically 
interact with a variety of macromolecules and 
particles (particularly cells) in a concentration 
dependent manner is documented. The polymer-linked 
affinity compounds of the invention can thus be used 
in a variety of applications when it is desired to 
achieve enhanced reduction of electrophoretic mobility 
in a controlled, concentration-dependent manner. 
The following examples are presented as 
illustrative only and are not intended to limit the 
scope of the invention in any way: 
10 
EXAMPLE I 
Electrophoretic mobility profiles of standard 
15 model cells (human erythrocytes) were obtained in 
phosphate buffered saline in a Rank Bros. cylindrical 
chamber cytopherometer set at 4 0  V DC. Standard cell 
mobility is roughly 1.1 micrometer per second per volt 
per cm (i.e., velocity per field strength) expressed 3 s4 
20 a s & n  s-l V-l cm. Five separate experiments with . 74*, 
polyethylene glycol-immunoglobulin used to treat the 
cells were run, and the results are observed in the 
graph of Figure 1. Each different immunoglob6lin is 
represented by a different symbol. The standard error 
25 associated with each measurement (point) was IO%, or 
less, of the mean. The results indicated that cell 
mobility was decreased for all PEG-immunoglobulin 
treated cells in a concentration dependent manner. 
The range of reduction ranged from roughly 1 ug to 1 
cell mobility effectively approached zero or a 100% 
reduction in mobility. It was also noted in these 
tests that cell aggregation normally associated with 
treatment by immunoglobulins alone was not observed 
with the PEG-immunoglobulin affinity compounds of the 
present invention. 
3 0  mg, and at the higher concentration levels of PEG-IgG, 
3 5  
-13- 
EXAMPLE IX 
5 
10 
15 
2 0  
25  
30 
The effe t of a PEG-fatty acid ester affinity 
compound on cell mobility was tested in the same 
manner as described in Example 1. The results of 
these tests can be observed in Figure 2 .  Tests were 
made on PEG alone (as a control), and on PEG-fatty 
acid ester combinations of varying fatty acyl tail 
length and saturation. The PEG employed in most of 
these trials had a molecular weight of roughly 8 0 0 0 ,  
and in one of the tests, a PEG of molecular weight of 
about 1000 was studied. The tests involved 3-5 trials 
for each of the affinity compounds as indicated in 
Figure 2 .  Typical standard deviation for each point 
was 5 lo%, or less, of the mean. The results again 
indicated that the PEG-fatty acid ester affinity 
compounds were successful in producing a 
concentration-dependent reduction in electrophoretic 
mobility of the treated cells. 
that the reduction in mobility was dependent upon the 
PEG head group molecular weight and the fatty acyl 
tail length and saturation. The particularly 
effective affinity compounds were those indicated at 
C-F in Figure 2 ,  wherein molecular weight of the PEG 
was around 8000, and the acyl tails of the compound 
had substantial tail length (hydrophobicity). The 
trials with lower molecular weight PEG and shorter 
tail length compounds both affected the mobility of 
the cells, but not as greatly as the effect observed 
with the compounds C-F. 
invention, although not as specific as the 
immuno-affinity compounds such as described in Example 
1, are advantageous in that they can be produced at 
It was also determined 
- 
The hydrophobic affinity compounds of the 
-14- 
low cost, and are easily reversible with regard to the 
cells treated. Most cells have similar native 
electrophoretic mobilities due to the nature of the 
surface charges involved. The affinity compounds of 
5 the present invention will therefore allow for the 
controlled electrophoretic separation of cells and 
other particles in a manner heretofore unachievable, 
using equipment already owned by many lzboratories. 
ABSTRACT OF THE D I S C L O S U R E  
A method  of r e d u c i n g  e l e c t r o p h o r e t i c  m o b i l i t y  o f  
m a c r o m o l e c u l e s ,  p a r t i c l e s ,  c e l l s  a n d  t h e  l i k e  i s  p r o v i d e d  
w h i c h  c o m p r i s e s  i n t e r a c t i n g  t h e  p a r t i c l e s  o r  c e l l s  w i t h  a 
5 p o l y m e r - l i n k e d  a f f i n i t y  compound c o m p r i s e d  o f :  a 
h y d r o p h i l i c  n e u t r a l  p o l y m e r  s u c h  as  p o l y e t h y l e n e  g l y c o l ,  
a n d  a n  a f f i n i t y  componen t  c o n s i s t i n g  of a h y d r o p h o b i c  
compound s u c h  a s  a f a t t y  a c i d  e s t e r ,  a n  immunocompound s u c h  
as  a n  a n t i b o d y  o r  a c t i v e  f r a g m e n t  t h e r e o f  o r  s imi l a r  
e l e c t r o p h o r e t i c  m o b i l i t y  a c h i e v e d  i s  d i r e c t l y  p r o p o r t i o n a l  
t o  t h e  c o n c e n t r a t i o n  o f  t h e  p o l y m e r - l i n k e d  a f f i n i t y  
compound e m p l o y e d ,  a n d  t h e  m o b i l i t y  r e d u c t i o n  o b t a i n a b l e  i s  
u p  t o  100% f o r  p a r t i c u l a r  p a r t i c l e s  a n d  c e l l s .  The  p r e s e n t  
e l e c t r o p h o r e t i c  s e p a r a t i o n  can n o t  b e  a c h i e v e d  f o r  
m a c r o m o l e c u l e s ,  p a r t i c l e s  a n d  c e l l s  whose  n a t i v e  s u r f a c e  
10 m a c r o m o l e c u l e ,  o r  o t h e r  l i g a n d s .  The r e d u c t i o n  of 
15 i n v e n t i o n  i s  a d v a n t a g e o u s  i n  t h a t  a n a l y t i c a l  
c h a r g e  s t r u c t u r e  had  p r e v e n t e d  t h e m  from b e i n g  s e p a r a t e d  by 
n o r m a l  e l e c t r o p h o r e t i c  means .  D e p e n d i n g  o n  t h e  a f f i n i t y  
o f  s p e c i f i c / i r r e v e r s i b l e ,  s p e c i f i c / r e v e r s i b l e ,  
semi-specific/reversible, r e l a t i v e l y  
n o n s p e c i f i c / r e v e r s i b l e ,  o r  r e l a t i v e l y  
nonspecific/irreversible l i g a n d - s u b s t a n c e  i n t e r a c t i o n s .  
u s e d  i n  a v a r i e t y  of s t a n d a r d  l a b o r a t o r y  e l e c t r o p h o r e s i s  
e q u i p m e n t .  
20 componen t  u t i l i z e d ,  s e p a r a t i o n  c a n  b e  a c h i e v e d  o n  t h e  b a s i s  
25 T h e  p r e s e n t  method i s  a l s o  a d v a n t a g e o u s  i n  t h a t  i t  c a n  be 
I 
